• Royalty Pharma average return on equity for 2023 was 4.84, a 22.84% increase from 2022.
• Royalty Pharma average return on equity for 2022 was 3.94, a 53.04% increase from 2021.
• Royalty Pharma average return on equity for 2021 was 8.39, a 52.19% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.